On this page
Back to topHemab Therapeutics Holdings COAG
Hemab Therapeutics Holdings listed on Nasdaq on 1 May 2026 and is not in the S&P 500. It is worth $1.9 billion. Its board is not in our data yet. At 30 Jun 2026, Ra Capital Management was its largest institutional holder, with 16.7% of the company.
- CEO
- Benny Sorensen
- Listed
- 1 May 2026 on Nasdaq, IPO filings and terms
- Headquarters
- Cambridge, MA
- Market cap
- $1.9B
- 19 Nov 2026 close
- Revenue
- -
- No annual report yet
Board and leadership
Board and officers
Hemab Therapeutics Holdings' board is not in our data yet. It listed on 1 May 2026 and has not filed a proxy statement. See its 8-K filings.
Owners and trading
Largest institutional holders
Each fund group's share of Hemab Therapeutics Holdings. Where a company has several share classes, the share is of its total value.
13F filings for the quarter to 30 Jun 2026
Insider trades
Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.
Trades from 19 Nov 2025 to 19 Nov 2026
Directors and officers made no open-market sales and bought $52.2 million in 3 purchases in the 12 months to 19 Nov 2026.
| Date | Person | Value |
|---|---|---|
| 6 May 2026Buy | Peter KolchinskyDirector | $1.7M |
| 5 May 2026Buy | Peter KolchinskyDirector | $2.4M |
| 4 May 2026Buy | Peter KolchinskyDirector | $48M |
Timeline
Leadership changes, layoffs and insider sales
20 Nov 2024 to 20 Nov 2026; insider sales from 19 Nov 2025
1 departure and 1 appointment of directors and officers in the last two years.
Events, newest first
- 24 Sep 2026 Keli Walbert appointedMember of the Board
- 8 May 2026 Laura Tadvalkar resignedMember of the Company's board of directors
Not on file: no weekly market cap history, no trades disclosed by members of Congress or officials since November 2023, no WARN layoff notices under its own name or a listed subsidiary's since November 2023, no open roles from its careers site yet, no earnings release figures from the last six months and no quarterly results in its SEC XBRL filings.